Dhakal Bishnu P, Malhotra Rajeev, Murphy Ryan M, Pappagianopoulos Paul P, Baggish Aaron L, Weiner Rory B, Houstis Nicholas E, Eisman Aaron S, Hough Stacyann S, Lewis Gregory D
From the Cardiology Division (B.P.D., R.M., R.M.M., A.L.B., R.B.W., N.E.H., A.S.E, G.D.L.) and the Pulmonary and Critical Care Unit (P.P.P., S.S.H., G.D.L.), Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston.
Circ Heart Fail. 2015 Mar;8(2):286-94. doi: 10.1161/CIRCHEARTFAILURE.114.001825. Epub 2014 Oct 24.
Exercise capacity as measured by peak oxygen uptake (Vo2) is similarly impaired in patients with heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF). However, characterization of how each component of Vo2 changes in response to incremental exercise in HFpEF versus HFrEF has not been previously defined. We hypothesized that abnormally low peripheral o2 extraction (arterio-mixed venous o2 content difference, [C(a-v)o2]) during exercise significantly contributes to impaired exercise capacity in HFpEF.
We performed maximum incremental cardiopulmonary exercise testing with invasive hemodynamic monitoring on 104 patients with symptomatic NYHA II to IV heart failure (HFpEF, n=48, peak Vo2=13.9±0.5 mL kg(-1) min(-1), mean±SEM, and HFrEF, n=56, peak Vo2=12.1±0.5 mL kg(-1) min(-1)) and 24 control subjects (peak Vo2 27.0±1.7 mL kg(-1) min(-1)). Peak exercise C(a-v)o2 was lower in HFpEF compared with HFrEF (11.5±0.27 versus 13.5±0.34 mL/dL, respectively, P<0.0001), despite no differences in age, hemoglobin level, peak respiratory exchange ratio, Cao2, or cardiac filling pressures. Peak C(a-v)o2 and peak heart rate emerged as the leading predictors of peak Vo2 in HFpEF. Impaired peripheral o2 extraction was the predominant limiting factor to exercise capacity in 40% of patients with HFpEF and was closely related to elevated systemic blood pressure during exercise (r=0.49, P=0.0005).
In the first study to directly measure C(a-v)o2 throughout exercise in HFpEF, HFrEF, and normals, we found that peak C(a-v)o2 was a major determinant of exercise capacity in HFpEF. The important functional limitation imposed by impaired o2 extraction may reflect intrinsic abnormalities in skeletal muscle or peripheral microvascular function, and represents a potential target for therapeutic intervention.
通过峰值摄氧量(Vo2)测量的运动能力在射血分数保留的心力衰竭(HFpEF)患者和射血分数降低的心力衰竭(HFrEF)患者中同样受损。然而,此前尚未明确HFpEF与HFrEF中Vo2的各个组成部分如何响应递增运动而变化。我们假设运动期间外周氧摄取异常低(动脉血-混合静脉血氧含量差,[C(a-v)o2])显著导致HFpEF患者运动能力受损。
我们对104例有症状的纽约心脏协会(NYHA)II至IV级心力衰竭患者(HFpEF,n = 48,峰值Vo2 = 13.9±0.5 mL·kg⁻¹·min⁻¹,均值±标准误,以及HFrEF,n = 56,峰值Vo2 = 12.1±0.5 mL·kg⁻¹·min⁻¹)和24名对照受试者(峰值Vo2 27.0±1.7 mL·kg⁻¹·min⁻¹)进行了带有有创血流动力学监测的最大递增心肺运动测试。尽管在年龄、血红蛋白水平、峰值呼吸交换率、动脉血氧含量(Cao2)或心脏充盈压方面无差异,但HFpEF患者运动峰值时的C(a-v)o2低于HFrEF患者(分别为11.5±0.27与13.5±0.34 mL/dL,P<0.0001)。峰值C(a-v)o2和峰值心率成为HFpEF患者峰值Vo2的主要预测因素。外周氧摄取受损是40%的HFpEF患者运动能力的主要限制因素,并且与运动期间升高的体循环血压密切相关(r = 0.49,P = 0.0005)。
在第一项直接测量HFpEF、HFrEF患者及正常人运动全程C(a-v)o2的研究中,我们发现峰值C(a-v)o2是HFpEF患者运动能力的主要决定因素。氧摄取受损所造成的重要功能限制可能反映了骨骼肌或外周微血管功能的内在异常,并且代表了一个潜在的治疗干预靶点。